The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Gilead Sciences to Present at Two Upcoming Investor Conferences

<p class='bwalignc'> <i><b>- NASDAQ OMX 26</b></i><sup><i><b>th</b></i></sup><i><b> Investor Program June 21</b></i><sup><i><b>st</b></i></sup><i><b> -</b></i> </p> <p class='bwalignc'> <i><b>- Wells Fargo Securities 2011 Healthcare Conference on June 22</b></i><sup><i><b>nd</b></i></sup><i><b> -</b></i> </p> <p class='bwalignc'> <i><b>- Webcasts Available Through Gilead Corporate Website -</b></i> </p>

Tuesday, June 14, 2011

Gilead Sciences to Present at Two Upcoming Investor Conferences16:30 EDT Tuesday, June 14, 2011 FOSTER CITY, Calif. (Business Wire) -- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company will be webcasting its corporate presentation at two upcoming investor conferences: the NASDAQ OMX Investor Program in London and the Wells Fargo Healthcare Conference in Boston. Patrick O'Brien, Gilead's Senior Director, Investor Relations, will provide an overview of the company at the NASDAQ OMX conference on Tuesday, June 21 at 8:00 a.m. Greenwich Mean Time [3:00 a.m. Eastern Daylight Time (EDT)]. Kevin Young, Gilead's Executive Vice President, Commercial Operations, will provide an overview of the company at the Wells Fargo conference on Wednesday, June 22 at 11:15 a.m. EDT. To access the live webcasts or replays via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation. About Gilead Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific. For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235). Gilead Sciences, Inc.Susan Hubbard, 650-522-5715Investor Relations